Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Phylogica, Grant for Phylomer Based Biosensor Device Received by Phylogica and University of Queensland (ASX:PYC)

PERTH, AUSTRALIA: 4 July 2013 – Phylogica Ltd (ASX: PYC, XETRA:PH7), a leading Australian peptide drug discovery company, announced today that it will receive a Linkage Grant from the Austral...read more

Phylogica, Collaboration with Janssen for Peptide-Drug Conjugates Expanded (ASX:PYC)

PERTH, AUSTRALIA: 01 July 2013 – Phylogica Ltd (ASX:PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today the expansion of its collaboration with Janssen Biot...read more

Phylogica, Technology to Discover Sophisticated Cell-Penetrating Drugs Patented (ASX:PYC)

PERTH, AUSTRALIA: 27 June 2013 – Leading peptide drug discovery company Phylogica Ltd (ASX: PYC, XETRA: PH7) has developed and patented an enhancement to its Phylomer peptide platform to disc...read more

Phylogica, European Patent Granted Covering Phylomer Peptides for Ischemia (ASX:PYC)

PERTH, AUSTRALIA: April 24, 2013 – Phylogica Ltd (ASX:PYC, XETRA: PH7), a leading Australian peptide drug discovery company, has been granted a new European patent (no. 1793841) entitled: &ls...read more

Phylogica, Financial Advisor to Assess Strategic Opportunities Engaged (ASX:PYC)

PERTH, AUSTRALIA: April 10, 2013 – Phylogica Ltd (ASX:PYC, XETRA:PH7), a leading Australian peptide drug discovery company, has engaged Griffin Securities, a specialty investment bank located...read more

PHYLOGICA GRANTED CORE PHYLOMER PATENT IN AUSTRALIA (ASX:PYC)

PERTH, AUSTRALIA: March 22, 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today that a core patent has been granted in Australia ...read more

Phylogica, Newsletter: Harnessing Natural Diversity for Drug Discovery (ASX:PYC)

In this edition: - Strategic Evolution - Extension of Janssen Collaboration - Monetisation of Assets - The Potential for Peptide Therapeutics - Unique Attr...read more

Phylogica Limited, Half Yearly Report and Accounts (ASX:PYC)

OPERATIONAL REVIEW The first half of 2013 has been a mixed period for Phylogica. There has been solid progress with existing partnerships and meaningful enhancements to the Phylomer platform. T...read more

Phylogica, Collaboration with Bio-Link to Commercialise Anti-Inflammatory Phylomers (ASX:PYC)

PERTH, AUSTRALIA: February 05, 2013 – Phylogica Ltd (ASX:PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today that it has entered an agreement with Bio-Link ...read more

Phylogica, Milestone Achieved in Pharma Collaboration (ASX:PYC)

PERTH, AUSTRALIA: January 31, 2013 – Phylogica Ltd (ASX:PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today the extension of its collaboration with Janssen ...read more

Phylogica, Harnessing Biodiversity for Peptide Therapies (ASX:PYC)

2012 highlights - Signed alliance with Janssen Biotech – our biggest and broadest deal to-date - Achieved Pfizer discovery milestone in therapeutic vaccine collaboration - Progres...read more

Phylogica, Letter to Shareholders (ASX:PYC)

Receive the latest news and announcements from Phylogica Limited (ASX:PYC) directly to your email and mobile Dear PYC Shareholder, In an effort to better serve our shareholders, Phylogica L...read more

Phylogica, Next Generation Phylomer Libraries Launched (ASX:PYC)

PERTH, AUSTRALIA: November 22, 2012 – Phylogica Ltd (ASX:PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today the successful completion of a major upgrade to...read more

Phylogica, Notice of Annual General Meeting (ASX:PYC)

TIME: 11.00 am WST DATE: Thursday, 22 November 2012 PLACE: Seminar Room Telethon Institute for Child Health Research 100 Roberts Road, Subiaco WA To view Notice please download P...read more

Phylogica, Converting Note Placement to Raise $1.6 Million (ASX:PYC)

PERTH, AUSTRALIA: October 16, 2012 – Phylogica Ltd (ASX:PYC, XETRA:PH7), an Australian peptide drug discovery company, announced today that it has agreed to raise $1.6 million of new capital ...read more

Viewing: 76 - 90 of 116 Previous | Next